참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | Diisopropylamine | HCID 7912 | — |
| 반응물 | 5-Chlorovaleryl chloride | HCID 74089 | — |
| 반응물 | 1-(4-Fluorophenyl)-4-(methylsulfonyl)piperazine | HCID 669039 | — |
| 반응물 | Lithium diisopropylamide | HCID 2724682 | — |
| 반응물 | Butyllithium | HCID 178418339 | — |
| 용매 | Tetrahydrofuran | HCID 8028 | — |
| 용매 | Ethyl Acetate | HCID 8857 | — |
| 생성물 | 1-(6-Chloro-2-hexanone-1-sulfonyl)-4-(4-fluorophenyl)piperazine | HCID 22719721 | 60% |
반응 단계
To a solution of LDA (51 mmol, prepared by slow addition of n-butyl lithium (20.4 ml, 2.5M in hexane, 51 mmol) to a solution of diisopropylamine (5.16 g, 51 mmol) in THF (30 ml) at −78° C.) at −78° C. was added a solution of 1-(4-fluorophenyl)-4-(methanesulfonyl)-piperazine (6 g, 23.2 mmol) in THF (150 ml). The mixture was stirred for 1 h at −78° C. A solution of 5-chlorovaleryl chloride (4 g, 25.8 mmol) in THF (20 ml) was added dropwise. The mixture was stirred at −78° C. for 1 h and at room temperature for 18 h. The solution was diluted with EtOAc and washed with sat. NH4Cl and brine and dried over MgSO4. Chromatography of the residue on silica gel (eluant:EtOAc—CH2Cl2—petroleum ether (15:35:50)) afforded 1-(6-chloro-2-hexanone-1-sulfonyl)-4-(4-fluorophenyl)piperazine (5.22 g, 60%) as white crystals: MS (ESI): 399 (MNa+).
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US07342020B2 |
|---|
| 출처 데이터셋 | uspto-grants-2008_03 |
|---|
| ORD ID | ord-80a9d8941d6b4987bc430332e5d8dc54 |
|---|
| 출처 메모 | uspto-grants-2008_03 |
|---|